{"transactions":[{"id":670911,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-09-01T23:08:43.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":61276,"derivative":{"exercise_price":24.59,"expiration_date":"2032-02-18","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-26-000118","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000118/form4.xml","form_type":"4"}},{"id":670910,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-01T23:08:43.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":46.986,"value":422874.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.8269 to $47.3197. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":65389,"source":{"system":"sec-edgar","filing":"0001520262-26-000118","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000118/form4.xml","form_type":"4"}},{"id":670909,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-01T23:08:43.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":24.59,"value":122950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":74389,"source":{"system":"sec-edgar","filing":"0001520262-26-000118","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000118/form4.xml","form_type":"4"}},{"id":698627,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-03T23:12:58.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":4896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested in accordance with their terms."}],"balance_after":66276,"derivative":{"exercise_price":24.59,"expiration_date":"2032-02-18","underlying":"Ordinary Shares","underlying_shares":4896},"source":{"system":"sec-edgar","filing":"0001520262-26-000110","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000110/form4.xml","form_type":"4"}},{"id":698626,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-03T23:12:58.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are fully vested in accordance with their terms."}],"balance_after":1252,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":104},"source":{"system":"sec-edgar","filing":"0001520262-26-000110","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000110/form4.xml","form_type":"4"}},{"id":698625,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-03T23:12:58.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":48.58,"value":437220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":69389,"source":{"system":"sec-edgar","filing":"0001520262-26-000110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000110/form4.xml","form_type":"4"}},{"id":698624,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-03T23:12:58.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":4896,"price":24.59,"value":120392.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":78389,"source":{"system":"sec-edgar","filing":"0001520262-26-000110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000110/form4.xml","form_type":"4"}},{"id":698623,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-03T23:12:58.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":104,"price":19.34,"value":2011.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":73493,"source":{"system":"sec-edgar","filing":"0001520262-26-000110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000110/form4.xml","form_type":"4"}},{"id":720765,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-07-01T22:29:17.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options are fully vested in accordance with their terms."}],"balance_after":1356,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-26-000103","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000103/form4.xml","form_type":"4"}},{"id":720764,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-01T22:29:17.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":700,"price":52.1314,"value":36491.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.10 to $52.17. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":73389,"source":{"system":"sec-edgar","filing":"0001520262-26-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000103/form4.xml","form_type":"4"}},{"id":720763,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-01T22:29:17.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":8300,"price":51.4613,"value":427128.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.06 to $52.04. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":74089,"source":{"system":"sec-edgar","filing":"0001520262-26-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000103/form4.xml","form_type":"4"}},{"id":720762,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-01T22:29:17.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":19.34,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":82389,"source":{"system":"sec-edgar","filing":"0001520262-26-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000103/form4.xml","form_type":"4"}},{"id":756759,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-06-01T23:26:49.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":6356,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-26-000097","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000097/form4.xml","form_type":"4"}},{"id":756758,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-01T23:26:49.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":41.6715,"value":375043.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.37 to $42.19. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":77389,"source":{"system":"sec-edgar","filing":"0001520262-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000097/form4.xml","form_type":"4"}},{"id":756757,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-01T23:26:49.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":19.34,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":86389,"source":{"system":"sec-edgar","filing":"0001520262-26-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000097/form4.xml","form_type":"4"}},{"id":795333,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-05-02T01:05:20.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":11356,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000072/form4.xml","form_type":"4"}},{"id":795332,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-05-02T01:05:20.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":33.3955,"value":300559.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.21 to $33.49. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":81389,"source":{"system":"sec-edgar","filing":"0001520262-26-000072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000072/form4.xml","form_type":"4"}},{"id":795331,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-05-02T01:05:20.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":19.34,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":90389,"source":{"system":"sec-edgar","filing":"0001520262-26-000072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000072/form4.xml","form_type":"4"}},{"id":822584,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-01T22:58:51.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":16356,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-26-000065","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000065/form4.xml","form_type":"4"}},{"id":822583,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-04-01T22:58:51.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":35.5116,"value":319604.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.50 to $35.62. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":85389,"source":{"system":"sec-edgar","filing":"0001520262-26-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000065/form4.xml","form_type":"4"}},{"id":822582,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-04-01T22:58:51.000Z","date":"2026-04-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":19.34,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":94389,"source":{"system":"sec-edgar","filing":"0001520262-26-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000065/form4.xml","form_type":"4"}},{"id":860891,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2026-03-05T01:16:25.000Z","date":"2026-03-02","kind":"grant","planned":true,"acquired":true,"shares":38568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027."}],"balance_after":38568,"derivative":{"underlying":"Ordinary Shares","underlying_shares":38568},"source":{"system":"sec-edgar","filing":"0001520262-26-000058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000058/form4.xml","form_type":"4"}},{"id":860890,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-05T01:16:25.000Z","date":"2026-03-02","kind":"grant","planned":true,"acquired":true,"shares":83037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027."}],"balance_after":83037,"derivative":{"exercise_price":30.25,"expiration_date":"2036-03-02","underlying":"Ordinary Shares","underlying_shares":83037},"source":{"system":"sec-edgar","filing":"0001520262-26-000058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000058/form4.xml","form_type":"4"}},{"id":860889,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-05T01:16:25.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":21356,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-26-000058","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000058/form4.xml","form_type":"4"}},{"id":860888,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T01:16:25.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":29.7206,"value":267485.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.29 to $30.13. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":89389,"source":{"system":"sec-edgar","filing":"0001520262-26-000058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000058/form4.xml","form_type":"4"}},{"id":860887,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T01:16:25.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":19.34,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":98389,"source":{"system":"sec-edgar","filing":"0001520262-26-000058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000058/form4.xml","form_type":"4"}},{"id":876716,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2026-02-27T21:38:26.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":6866,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025."}],"balance_after":13732,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6866},"source":{"system":"sec-edgar","filing":"0001520262-26-000046","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000046/form4.xml","form_type":"4"}},{"id":876715,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-27T21:38:26.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3049,"price":30.73,"value":93695.77,"ownership":{"direct":true},"balance_after":93389,"source":{"system":"sec-edgar","filing":"0001520262-26-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000046/form4.xml","form_type":"4"}},{"id":876714,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-27T21:38:26.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":6866,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":96438,"source":{"system":"sec-edgar","filing":"0001520262-26-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000046/form4.xml","form_type":"4"}},{"id":881517,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2026-02-25T22:46:04.000Z","date":"2026-02-23","kind":"exercise","planned":false,"acquired":false,"shares":7689,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024."}],"balance_after":7690,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7689},"source":{"system":"sec-edgar","filing":"0001520262-26-000033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000033/form4.xml","form_type":"4"}},{"id":881516,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-25T22:46:04.000Z","date":"2026-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":3414,"price":32.19,"value":109896.66,"ownership":{"direct":true},"balance_after":89572,"source":{"system":"sec-edgar","filing":"0001520262-26-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000033/form4.xml","form_type":"4"}},{"id":881515,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-25T22:46:04.000Z","date":"2026-02-23","kind":"exercise","planned":false,"acquired":true,"shares":7689,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":92986,"source":{"system":"sec-edgar","filing":"0001520262-26-000033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000033/form4.xml","form_type":"4"}},{"id":890303,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2026-02-20T21:22:32.000Z","date":"2026-02-19","kind":"exercise","planned":false,"acquired":false,"shares":7673,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026."}],"balance_after":23019,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7673},"source":{"system":"sec-edgar","filing":"0001520262-26-000026","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000026/form4.xml","form_type":"4"}},{"id":890302,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2026-02-20T21:22:32.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":8897,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8897},"source":{"system":"sec-edgar","filing":"0001520262-26-000026","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000026/form4.xml","form_type":"4"}},{"id":890301,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-20T21:22:32.000Z","date":"2026-02-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":3407,"price":32,"value":109024.0,"ownership":{"direct":true},"balance_after":85297,"source":{"system":"sec-edgar","filing":"0001520262-26-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000026/form4.xml","form_type":"4"}},{"id":890300,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-20T21:22:32.000Z","date":"2026-02-19","kind":"exercise","planned":false,"acquired":true,"shares":7673,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":88704,"source":{"system":"sec-edgar","filing":"0001520262-26-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000026/form4.xml","form_type":"4"}},{"id":890299,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-20T21:22:32.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":3504,"price":32.02,"value":112198.08,"ownership":{"direct":true},"balance_after":81031,"source":{"system":"sec-edgar","filing":"0001520262-26-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000026/form4.xml","form_type":"4"}},{"id":890298,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-20T21:22:32.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":8897,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":84535,"source":{"system":"sec-edgar","filing":"0001520262-26-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000026/form4.xml","form_type":"4"}},{"id":915808,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-07T00:11:58.000Z","date":"2026-02-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":7454,"price":33.55,"value":250081.7,"ownership":{"direct":true},"balance_after":75638,"source":{"system":"sec-edgar","filing":"0001520262-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000016/form4.xml","form_type":"4"}},{"id":915807,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-07T00:11:58.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":25352,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These ordinary shares were acquired by the reporting person as a result of the vesting of performance-vesting restricted stock unit awards granted to the reporting person on February 23, 2023 with a three-year performance period that ended on December 31, 2025 (the \"2023 PRSUs\"). The vesting of this portion of the 2023 PRSUs was triggered by the determination of achievement of certain pre-specified performance goals and application of a relative total shareholder return modifier and represents the final vesting event under the 2023 PRSUs."}],"balance_after":83092,"source":{"system":"sec-edgar","filing":"0001520262-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000016/form4.xml","form_type":"4"}},{"id":924570,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-03T01:52:08.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":26356,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-26-000009","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000009/form4.xml","form_type":"4"}},{"id":924569,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-03T01:52:08.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":33.54,"value":134160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":57740,"source":{"system":"sec-edgar","filing":"0001520262-26-000009","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000009/form4.xml","form_type":"4"}},{"id":924568,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-03T01:52:08.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":34.2449,"value":171224.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.67 to $34.64. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":61740,"source":{"system":"sec-edgar","filing":"0001520262-26-000009","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000009/form4.xml","form_type":"4"}},{"id":924567,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-03T01:52:08.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":19.34,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":66740,"source":{"system":"sec-edgar","filing":"0001520262-26-000009","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000009/form4.xml","form_type":"4"}},{"id":943075,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-01-08T22:23:14.000Z","date":"2026-01-08","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":31356,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-26-000004","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000004/form4.xml","form_type":"4"}},{"id":943074,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-08T22:23:14.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":30.001,"value":150005.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":61740,"source":{"system":"sec-edgar","filing":"0001520262-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000004/form4.xml","form_type":"4"}},{"id":943073,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-08T22:23:14.000Z","date":"2026-01-08","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":19.34,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":66740,"source":{"system":"sec-edgar","filing":"0001520262-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000004/form4.xml","form_type":"4"}},{"id":954944,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-02T21:39:39.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":28,"value":112000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":61740,"source":{"system":"sec-edgar","filing":"0001520262-26-000002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026226000002/form4.xml","form_type":"4"}},{"id":978794,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-05T21:21:33.000Z","date":"2025-12-03","kind":"exercise","planned":true,"acquired":false,"shares":3748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":36356,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":3748},"source":{"system":"sec-edgar","filing":"0001520262-25-000014","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026225000014/form4.xml","form_type":"4"}},{"id":978793,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-05T21:21:33.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":3748,"price":30.0019,"value":112447.1212,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.03. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":65740,"source":{"system":"sec-edgar","filing":"0001520262-25-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026225000014/form4.xml","form_type":"4"}},{"id":978792,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-05T21:21:33.000Z","date":"2025-12-03","kind":"exercise","planned":true,"acquired":true,"shares":3748,"price":19.34,"value":72486.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":69488,"source":{"system":"sec-edgar","filing":"0001520262-25-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026225000014/form4.xml","form_type":"4"}},{"id":984858,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-01T22:41:32.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":29.3,"value":117200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":65740,"source":{"system":"sec-edgar","filing":"0001520262-25-000012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026225000012/form4.xml","form_type":"4"}},{"id":1009433,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-11-03T21:37:40.000Z","date":"2025-11-03","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":40104,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-25-000010","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026225000010/form4.xml","form_type":"4"}},{"id":1009432,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-03T21:37:40.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":30.3824,"value":273441.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.34 to $30.56. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":69740,"source":{"system":"sec-edgar","filing":"0001520262-25-000010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026225000010/form4.xml","form_type":"4"}},{"id":1009431,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-03T21:37:40.000Z","date":"2025-11-03","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":19.34,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":78740,"source":{"system":"sec-edgar","filing":"0001520262-25-000010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026225000010/form4.xml","form_type":"4"}},{"id":1018289,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-10-15T22:47:05.000Z","date":"2025-10-15","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":45104,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001520262-25-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026225000008/form4.xml","form_type":"4"}},{"id":1018288,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-10-15T22:47:05.000Z","date":"2025-10-15","kind":"sale","planned":true,"acquired":false,"shares":9000,"price":31.5307,"value":283776.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."},{"field":"shares","element":"transactionShares","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.51 to $31.60. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":73740,"source":{"system":"sec-edgar","filing":"0001520262-25-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026225000008/form4.xml","form_type":"4"}},{"id":1018287,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-10-15T22:47:05.000Z","date":"2025-10-15","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":19.34,"value":96700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025."}],"balance_after":82740,"source":{"system":"sec-edgar","filing":"0001520262-25-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000152026225000008/form4.xml","form_type":"4"}},{"id":1238011,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2025-02-28T22:16:29.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":6866,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025."}],"balance_after":20598,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6866},"source":{"system":"sec-edgar","filing":"0001127602-25-007313","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225007313/form4.xml","form_type":"4"}},{"id":1238010,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-28T22:16:29.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3049,"price":34.795,"value":106089.955,"ownership":{"direct":true},"balance_after":77740,"source":{"system":"sec-edgar","filing":"0001127602-25-007313","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225007313/form4.xml","form_type":"4"}},{"id":1238009,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-28T22:16:29.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":6866,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":80789,"source":{"system":"sec-edgar","filing":"0001127602-25-007313","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225007313/form4.xml","form_type":"4"}},{"id":1245402,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2025-02-25T23:35:58.000Z","date":"2025-02-23","kind":"exercise","planned":false,"acquired":false,"shares":7689,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024."}],"balance_after":15379,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7689},"source":{"system":"sec-edgar","filing":"0001127602-25-006718","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225006718/form4.xml","form_type":"4"}},{"id":1245401,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2025-02-25T23:35:58.000Z","date":"2025-02-22","kind":"exercise","planned":false,"acquired":false,"shares":12279,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12279},"source":{"system":"sec-edgar","filing":"0001127602-25-006718","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225006718/form4.xml","form_type":"4"}},{"id":1245400,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-25T23:35:58.000Z","date":"2025-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":3414,"price":35.32,"value":120582.48,"ownership":{"direct":true},"balance_after":73923,"source":{"system":"sec-edgar","filing":"0001127602-25-006718","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225006718/form4.xml","form_type":"4"}},{"id":1245399,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-25T23:35:58.000Z","date":"2025-02-23","kind":"exercise","planned":false,"acquired":true,"shares":7689,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":77337,"source":{"system":"sec-edgar","filing":"0001127602-25-006718","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225006718/form4.xml","form_type":"4"}},{"id":1245398,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-25T23:35:58.000Z","date":"2025-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":5452,"price":35.32,"value":192564.64,"ownership":{"direct":true},"balance_after":69648,"source":{"system":"sec-edgar","filing":"0001127602-25-006718","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225006718/form4.xml","form_type":"4"}},{"id":1245397,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-25T23:35:58.000Z","date":"2025-02-22","kind":"exercise","planned":false,"acquired":true,"shares":12279,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":75100,"source":{"system":"sec-edgar","filing":"0001127602-25-006718","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225006718/form4.xml","form_type":"4"}},{"id":1255200,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2025-02-20T22:13:46.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":30692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026."}],"balance_after":30692,"derivative":{"underlying":"Ordinary Shares","underlying_shares":30692},"source":{"system":"sec-edgar","filing":"0001127602-25-006033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225006033/form4.xml","form_type":"4"}},{"id":1255199,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-20T22:13:46.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":63991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/19/2026."}],"balance_after":63991,"derivative":{"exercise_price":35.84,"expiration_date":"2035-02-19","underlying":"Ordinary Shares","underlying_shares":63991},"source":{"system":"sec-edgar","filing":"0001127602-25-006033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225006033/form4.xml","form_type":"4"}},{"id":1255198,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Restricted Stock Unit Award","published_at":"2025-02-20T22:13:46.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":false,"shares":8896,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023."}],"balance_after":8897,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8896},"source":{"system":"sec-edgar","filing":"0001127602-25-006033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225006033/form4.xml","form_type":"4"}},{"id":1255197,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-20T22:13:46.000Z","date":"2025-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":3950,"price":35.9,"value":141805.0,"ownership":{"direct":true},"balance_after":62821,"source":{"system":"sec-edgar","filing":"0001127602-25-006033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225006033/form4.xml","form_type":"4"}},{"id":1255196,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-20T22:13:46.000Z","date":"2025-02-18","kind":"exercise","planned":false,"acquired":true,"shares":8896,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":66771,"source":{"system":"sec-edgar","filing":"0001127602-25-006033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225006033/form4.xml","form_type":"4"}},{"id":1266804,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-14T22:12:29.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":false,"shares":35586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023."}],"balance_after":71172,"derivative":{"exercise_price":24.59,"expiration_date":"2032-02-18","underlying":"Ordinary Shares","underlying_shares":35586},"source":{"system":"sec-edgar","filing":"0001127602-25-004948","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225004948/form4.xml","form_type":"4"}},{"id":1266803,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-14T22:12:29.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":false,"shares":108833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options are fully vested in accordance with their terms."}],"balance_after":0,"derivative":{"exercise_price":31.93,"expiration_date":"2029-02-21","underlying":"Ordinary Shares","underlying_shares":108833},"source":{"system":"sec-edgar","filing":"0001127602-25-004948","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225004948/form4.xml","form_type":"4"}},{"id":1266802,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-14T22:12:29.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":false,"shares":111630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022."}],"balance_after":50104,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":111630},"source":{"system":"sec-edgar","filing":"0001127602-25-004948","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225004948/form4.xml","form_type":"4"}},{"id":1266801,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-14T22:12:29.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":false,"shares":87566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options are fully vested in accordance with their terms."}],"balance_after":0,"derivative":{"exercise_price":20.03,"expiration_date":"2030-02-20","underlying":"Ordinary Shares","underlying_shares":87566},"source":{"system":"sec-edgar","filing":"0001127602-25-004948","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225004948/form4.xml","form_type":"4"}},{"id":1266800,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-14T22:12:29.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":108833,"price":36.0185,"value":3920001.4105,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.00 to $36.05. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":57875,"source":{"system":"sec-edgar","filing":"0001127602-25-004948","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225004948/form4.xml","form_type":"4"}},{"id":1266799,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-14T22:12:29.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":35586,"price":34.0217,"value":1210696.2162,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.00 to $34.07. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":166708,"source":{"system":"sec-edgar","filing":"0001127602-25-004948","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225004948/form4.xml","form_type":"4"}},{"id":1266798,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-14T22:12:29.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":true,"shares":35586,"price":24.59,"value":875059.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."}],"balance_after":202294,"source":{"system":"sec-edgar","filing":"0001127602-25-004948","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225004948/form4.xml","form_type":"4"}},{"id":1266797,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-14T22:12:29.000Z","date":"2025-02-13","kind":"exercise","planned":true,"acquired":true,"shares":108833,"price":31.93,"value":3475037.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."}],"balance_after":166708,"source":{"system":"sec-edgar","filing":"0001127602-25-004948","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225004948/form4.xml","form_type":"4"}},{"id":1266796,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-14T22:12:29.000Z","date":"2025-02-12","kind":"sale","planned":true,"acquired":false,"shares":33108,"price":33.269,"value":1101470.052,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.00 to $33.52. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":57875,"source":{"system":"sec-edgar","filing":"0001127602-25-004948","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225004948/form4.xml","form_type":"4"}},{"id":1266795,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-14T22:12:29.000Z","date":"2025-02-12","kind":"sale","planned":true,"acquired":false,"shares":171813,"price":32.6914,"value":5616807.5082,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.9998. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":90983,"source":{"system":"sec-edgar","filing":"0001127602-25-004948","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225004948/form4.xml","form_type":"4"}},{"id":1266794,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-14T22:12:29.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":true,"shares":111630,"price":19.34,"value":2158924.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."}],"balance_after":262796,"source":{"system":"sec-edgar","filing":"0001127602-25-004948","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225004948/form4.xml","form_type":"4"}},{"id":1266793,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-14T22:12:29.000Z","date":"2025-02-12","kind":"exercise","planned":true,"acquired":true,"shares":87566,"price":20.03,"value":1753946.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."}],"balance_after":151166,"source":{"system":"sec-edgar","filing":"0001127602-25-004948","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225004948/form4.xml","form_type":"4"}},{"id":1278460,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-08T01:31:42.000Z","date":"2025-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":15083,"price":31.39,"value":473455.37,"ownership":{"direct":true},"balance_after":63600,"source":{"system":"sec-edgar","filing":"0001127602-25-003679","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225003679/form4.xml","form_type":"4"}},{"id":1278459,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-08T01:31:42.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":34393,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These ordinary shares were acquired by the reporting person as a result of the vesting of performance-vesting restricted stock unit awards granted to the reporting person on February 18, 2022 with a three-year performance period that ended on December 31, 2024 (the \"2022 PRSUs\"). The vesting of this portion of the 2022 PRSUs was triggered by the determination of achievement of certain pre-specified performance goals and application of a total shareholder return modifier and represents the final vesting event under the 2022 PRSUs."}],"balance_after":78683,"source":{"system":"sec-edgar","filing":"0001127602-25-003679","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225003679/form4.xml","form_type":"4"}},{"id":1289205,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-01T01:42:16.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":false,"shares":18345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/23/2024."}],"balance_after":92271,"derivative":{"exercise_price":26.82,"expiration_date":"2033-02-23","underlying":"Ordinary Shares","underlying_shares":18345},"source":{"system":"sec-edgar","filing":"0001127602-25-002645","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225002645/form4.xml","form_type":"4"}},{"id":1289204,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-01T01:42:16.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":false,"shares":23542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023."}],"balance_after":106758,"derivative":{"exercise_price":24.59,"expiration_date":"2032-02-18","underlying":"Ordinary Shares","underlying_shares":23542},"source":{"system":"sec-edgar","filing":"0001127602-25-002645","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225002645/form4.xml","form_type":"4"}},{"id":1289203,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-01T01:42:16.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":false,"shares":26589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022."}],"balance_after":161734,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":26589},"source":{"system":"sec-edgar","filing":"0001127602-25-002645","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225002645/form4.xml","form_type":"4"}},{"id":1289202,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-01T01:42:16.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":false,"shares":29156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":87566,"derivative":{"exercise_price":20.03,"expiration_date":"2030-02-20","underlying":"Ordinary Shares","underlying_shares":29156},"source":{"system":"sec-edgar","filing":"0001127602-25-002645","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225002645/form4.xml","form_type":"4"}},{"id":1289201,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-01T01:42:16.000Z","date":"2025-01-30","kind":"sale","planned":true,"acquired":false,"shares":100918,"price":32.0496,"value":3234381.5328,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.17. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":44290,"source":{"system":"sec-edgar","filing":"0001127602-25-002645","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225002645/form4.xml","form_type":"4"}},{"id":1289200,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-01T01:42:16.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":true,"shares":18345,"price":26.82,"value":492012.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."}],"balance_after":145208,"source":{"system":"sec-edgar","filing":"0001127602-25-002645","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225002645/form4.xml","form_type":"4"}},{"id":1289199,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-01T01:42:16.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":true,"shares":23542,"price":24.59,"value":578897.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."}],"balance_after":126863,"source":{"system":"sec-edgar","filing":"0001127602-25-002645","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225002645/form4.xml","form_type":"4"}},{"id":1289198,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-01T01:42:16.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":true,"shares":26589,"price":19.34,"value":514231.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."}],"balance_after":103321,"source":{"system":"sec-edgar","filing":"0001127602-25-002645","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225002645/form4.xml","form_type":"4"}},{"id":1289197,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-01T01:42:16.000Z","date":"2025-01-30","kind":"exercise","planned":true,"acquired":true,"shares":29156,"price":20.03,"value":583994.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."}],"balance_after":76732,"source":{"system":"sec-edgar","filing":"0001127602-25-002645","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760225002645/form4.xml","form_type":"4"}},{"id":1338707,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-10T01:53:52.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":false,"shares":12411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/23/2024."}],"balance_after":110616,"derivative":{"exercise_price":26.82,"expiration_date":"2033-02-23","underlying":"Ordinary Shares","underlying_shares":12411},"source":{"system":"sec-edgar","filing":"0001127602-24-028885","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224028885/form4.xml","form_type":"4"}},{"id":1338706,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-10T01:53:52.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":false,"shares":12044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023."}],"balance_after":130300,"derivative":{"exercise_price":24.59,"expiration_date":"2032-02-18","underlying":"Ordinary Shares","underlying_shares":12044},"source":{"system":"sec-edgar","filing":"0001127602-24-028885","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224028885/form4.xml","form_type":"4"}},{"id":1338705,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-10T01:53:52.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":false,"shares":12090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022."}],"balance_after":188323,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":12090},"source":{"system":"sec-edgar","filing":"0001127602-24-028885","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224028885/form4.xml","form_type":"4"}},{"id":1338704,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-10T01:53:52.000Z","date":"2024-12-09","kind":"exercise","planned":true,"acquired":false,"shares":12452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":116722,"derivative":{"exercise_price":20.03,"expiration_date":"2030-02-20","underlying":"Ordinary Shares","underlying_shares":12452},"source":{"system":"sec-edgar","filing":"0001127602-24-028885","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224028885/form4.xml","form_type":"4"}},{"id":1338703,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":17870,"kind":"person","name":"Hopkinson Craig C.","position":1,"cik":"0001730048","reported_name":"Hopkinson Craig C.","relationship":{"officer":true,"officer_title":"EVP R&D, Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2024-12-10T01:53:52.000Z","date":"2024-12-09","kind":"sale","planned":true,"acquired":false,"shares":61151,"price":32.0748,"value":1961406.0948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.2514. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":47576,"source":{"system":"sec-edgar","filing":"0001127602-24-028885","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1520262/000112760224028885/form4.xml","form_type":"4"}}],"next_cursor":"2024-12-10T01:53:52.000000Z,1338703"}